Your browser doesn't support javascript.
loading
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.
Launay, Odile; Abitbol, Vered; Krivine, Anne; Slama, Lilia Ben; Bourreille, Arnaud; Dupas, Jean Louis; Hébuterne, Xavier; Savoye, Guillaume; Deplanque, Dominique; Bouhnik, Yoram; Pelletier, Anne Laure; Galtier, Florence; Laharie, David; Nachury, Maria; Zerbib, Frank; Allez, Mathieu; Bommelaer, Gilles; Duclos, Bernard; Lucht, Frederic; Gougeon, Marie-Lise; Tartour, Eric; Rozenberg, Flore; Hanslik, Thomas; Beaugerie, Laurent; Carrat, Fabrice.
Affiliation
  • Launay O; Université Paris Descartes, Sorbonne Paris Cité, Paris, France Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Cochin, CIC Cochin-Pasteur, Paris, France INSERM, CIC 1417, Paris, France INSERM, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France odile.launay@c
  • Abitbol V; AP-HP, Hôpital Cochin, Service de gastro-entérologie, Paris, France.
  • Krivine A; AP-HP, Hôpital Cochin, Service de virologie, Paris, France.
  • Slama LB; Assistance Publique Hôpitaux de Paris (AP-HP), Hôpital Cochin, CIC Cochin-Pasteur, Paris, France.
  • Bourreille A; CHU Nantes, Hôtel Dieu, Nantes, France.
  • Dupas JL; Service d'Hépatogastroentérologie, Hôpital Nord, Amiens, France.
  • Hébuterne X; Hôpital de l'Archet, Fédération d'Hépatogastroentérologie et de nutrition clinique, Nice, France.
  • Savoye G; Service Hépatogastroentérologie et Nutrition, Hôpital Charles Nicolle, Rouen, France.
  • Deplanque D; INSERM, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France INSERM-CHRU de Lille, CIC 1403, Lille, France.
  • Bouhnik Y; Hôpital Beaujon, Service de Gastroentérologie et Assistance Nutritive, Clichy, France.
  • Pelletier AL; Service de Gastroentérologie, Hôpital Bichat Claude Bernard, Paris, France.
  • Galtier F; INSERM, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France INSERM, CIC de Montpellier, Hôpital Saint Eloi, Montpellier, France.
  • Laharie D; Service d'Hépatogastroentérologie, Hôpital Haut-Lévêque, Pessac, France.
  • Nachury M; Service de Gastroentérologie, CHU Jean Minjoz, Besançon, and Service d'Hépatogastroentérologie, Hôpital Claude Huriez, Lille, France.
  • Zerbib F; Service d'Hépato-gastroentérologie, Hôpital Saint-André, Bordeaux, France.
  • Allez M; Service de Gastroentérologie, AP-HP, Hôpital Saint-Louis, Paris, France.
  • Bommelaer G; Service de Médecine Digestive et Hépatobiliaire, CHU Estaing, Clermont-Ferrand, France.
  • Duclos B; Hôpitaux Universitaires de Strasbourg, Service d'Hépato gastroentérologie, Hôpital de Hautepierre, INSERM U1113, Strasbourg, France.
  • Lucht F; INSERM, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France CHU Saint Etienne, Service des Maladies Infectieuses et tropicales, Saint Etienne, France.
  • Gougeon ML; INSERM, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Institut Pasteur, Paris, France.
  • Tartour E; Université Paris Descartes, Sorbonne Paris Cité, Paris, France INSERM, F-CRIN, Innovative clinical research network in vaccinology (I-REIVAC), Paris, France Hôpital Européen Georges Pompidou, Service d'Immunologie Biologique, INSERM, UMR_S 970, PARCC, Paris, France.
  • Rozenberg F; Université Paris Descartes, Sorbonne Paris Cité, Paris, France AP-HP, Hôpital Cochin, Service de virologie, Paris, France.
  • Hanslik T; Service de médecine interne, AP-HP; Hôpital Ambroise Paré, Université de Versailles Saint-Quentin-en-Yvelines, Boulogne-Billancourt, France.
  • Beaugerie L; Service de Gastroentérologie, AP-HP, Hôpital Saint-Antoine et INSERM/UMRS 7203, UPMC Université de Paris VI, Paris, France.
  • Carrat F; Département de santé publique, AP-HP, Hôpital Saint-Antoine, Paris, France Université Pierre et Marie Curie, UMR-S 1136, Paris, France INSERM, U1136, Paris, France.
J Crohns Colitis ; 9(12): 1096-107, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26351392
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines / Inflammatory Bowel Diseases / Influenza, Human / Influenza A Virus, H1N1 Subtype / Influenza A Virus, H3N2 Subtype / Immunosuppressive Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Crohns Colitis Journal subject: GASTROENTEROLOGIA Year: 2015 Type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines / Inflammatory Bowel Diseases / Influenza, Human / Influenza A Virus, H1N1 Subtype / Influenza A Virus, H3N2 Subtype / Immunosuppressive Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Crohns Colitis Journal subject: GASTROENTEROLOGIA Year: 2015 Type: Article Affiliation country: France